102 related articles for article (PubMed ID: 1702899)
1. Effects of isoprinosine treatment of HIV-positive patients on blood mononuclear cell subsets, NK- and T-cell function, tumour necrosis factor, and interleukins 1, 2, and 6.
Pedersen BK; Tvede N; Diamant M; Gerstoft J; Bagge Hansen M; Haahr PM; Hørding M; Kappel M; Klokker M; Søeberg B
Scand J Immunol; 1990 Dec; 32(6):641-9. PubMed ID: 1702899
[TBL] [Abstract][Full Text] [Related]
2. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro.
Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K
Nephron; 1987; 46(3):243-6. PubMed ID: 2442634
[TBL] [Abstract][Full Text] [Related]
3. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
[TBL] [Abstract][Full Text] [Related]
4. Isoprinosine potentiation of human peripheral blood mononuclear cell response to mitogens: kinetics and effect on expression of the IL-2 receptor and the activity of interleukin 2.
Lomnitzer R
J Clin Lab Immunol; 1988 Oct; 27(2):91-6. PubMed ID: 2469797
[TBL] [Abstract][Full Text] [Related]
5. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
[TBL] [Abstract][Full Text] [Related]
6. Effect of isoprinosine on natural killer cell activity of blood mononuclear cells in vitro and in vivo.
Hersey P; Edwards A
Int J Immunopharmacol; 1984; 6(4):315-20. PubMed ID: 6207121
[TBL] [Abstract][Full Text] [Related]
7. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.
Wiranowska-Stewart M; Hadden JW
Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734
[TBL] [Abstract][Full Text] [Related]
8. Isoprinosine affects serum cytokine levels in healthy adults.
Petrova M; Jelev D; Ivanova A; Krastev Z
J Interferon Cytokine Res; 2010 Apr; 30(4):223-8. PubMed ID: 20038210
[TBL] [Abstract][Full Text] [Related]
9. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
[TBL] [Abstract][Full Text] [Related]
10. Effect of isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in pokeweed mitogen stimulated cultures of B and T cells.
Hersey P; Bindon C; Bradley M; Hasic E
Int J Immunopharmacol; 1984; 6(4):321-8. PubMed ID: 6207122
[TBL] [Abstract][Full Text] [Related]
11. Effect of isoprinosine on IL-2, IFN-gamma and IL-4 production in vivo and in vitro.
Milano S; Dieli M; Millott S; Miceli MD; Maltese E; Cillari E
Int J Immunopharmacol; 1991; 13(7):1013-8. PubMed ID: 1722191
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals.
Klein SA; Dobmeyer JM; Dobmeyer TS; Falke D; Kabelitz D; Friese K; Helm EB; Hoelzer D; Rossol-Voth R
Eur J Med Res; 1996 Feb; 1(5):249-58. PubMed ID: 9374446
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes.
Lasek W; Janyst M; Wolny R; Zapała Ł; Bocian K; Drela N
Acta Pharm; 2015 Jun; 65(2):171-80. PubMed ID: 26011933
[TBL] [Abstract][Full Text] [Related]
14. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
Morin A; Griscelli C; Daguillard F
Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium.
Salvo G; Samoggia P; Masciulli R; Boccoli G; Allavena P; Mariani G; Bullo A; Montesoro E; Bulgarini D; Carlini P
Eur J Cancer; 1992; 28A(4-5):818-25. PubMed ID: 1524901
[TBL] [Abstract][Full Text] [Related]
16. Effects of isoprinosine in animal models of depressed T-cell function.
Binderup L
Int J Immunopharmacol; 1985; 7(1):93-101. PubMed ID: 2581907
[TBL] [Abstract][Full Text] [Related]
17. In vitro restoration of immune responses in aging humans by isoprinosine.
Tsang KY; Pan JF; Swanger DL; Fudenberg HH
Int J Immunopharmacol; 1985; 7(2):199-206. PubMed ID: 2409037
[TBL] [Abstract][Full Text] [Related]
18. Influence of isoprinosine on lymphocyte function in virus-infected feeder pigs.
Flaming KP; Blecha F; Fedorka-Cray PJ; Anderson GA
Am J Vet Res; 1989 Oct; 50(10):1653-7. PubMed ID: 2478051
[TBL] [Abstract][Full Text] [Related]
19. The selectivity of isoprinosine, NPT 15392, avridine and cyclophosphamide on multiple immune responses in rats.
Exon JH; Henningsen GM; Koller LD; Talcott PA
Int J Immunopharmacol; 1986; 8(1):53-62. PubMed ID: 2420733
[TBL] [Abstract][Full Text] [Related]
20. Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.
Tsang KY; Fudenberg HH; Galbraith GM; Donnelly RP; Bishop LR; Koopmann WR
J Clin Invest; 1985 May; 75(5):1538-44. PubMed ID: 2581997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
